Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
BMJ Open
|
October 1, 2020
Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial
Felix J Hüttner, Ilse Rooman, Gauthier Bouche, et al.
The Lancet. Oncology
|
May 3, 2025
Determining the optimal use of approved drugs in oncology
Gauthier Bouche, Duncan Gilbert, Matteo Quartagno, et al.
Annals of Intensive Care
|
September 23, 2021
High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study
Antoine Dewitte, Aurore Labat, Pierre-Antoine Duvignaud, et al.
Ecancermedicalscience
|
January 26, 2019
ReDO_DB: the repurposing drugs in oncology database
Pan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 27, 2025
Increased hospital case volume is associated with improved survival and quality of care for uterine corpus cancer in Belgium
Joren Vanbraband, Nancy Van Damme, Geert Silversmit, et al.
BMC Pharmacology & Toxicology
|
January 24, 2026
Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trials
Duncan C Gilbert, Ruth E Langley, Dami Ayadi, et al.
Frontiers in Pharmacology
|
April 2, 2021
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung)
Daniel Heudobler, Christian Schulz, Jürgen R Fischer, et al.
JCO Global Oncology
|
April 28, 2021
Trends in International Cancer Research Investment 2006-2018
Rachel Abudu, Gauthier Bouche, Karima Bourougaa, et al.
Cancers
|
April 13, 2023
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
Pierre Leblond, Emmanuelle Tresch-Bruneel, Alicia Probst, et al.
Plos One
|
December 5, 2019
Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial
Patrice Forget, Gauthier Bouche, Francois P Duhoux, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
BMJ Open
|
October 1, 2020
Pancreatic resection with perioperative drug repurposing of propranolol and etodolac: trial protocol of the phase-II randomised placebo controlled PROSPER trial
Felix J Hüttner, Ilse Rooman, Gauthier Bouche, et al.
The Lancet. Oncology
|
May 3, 2025
Determining the optimal use of approved drugs in oncology
Gauthier Bouche, Duncan Gilbert, Matteo Quartagno, et al.
Annals of Intensive Care
|
September 23, 2021
High mean arterial pressure target to improve sepsis-associated acute kidney injury in patients with prior hypertension: a feasibility study
Antoine Dewitte, Aurore Labat, Pierre-Antoine Duvignaud, et al.
Ecancermedicalscience
|
January 26, 2019
ReDO_DB: the repurposing drugs in oncology database
Pan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 27, 2025
Increased hospital case volume is associated with improved survival and quality of care for uterine corpus cancer in Belgium
Joren Vanbraband, Nancy Van Damme, Geert Silversmit, et al.
BMC Pharmacology & Toxicology
|
January 24, 2026
Drug re-purposing to improve outcomes in the management of prostate cancer - aims, outcome measures and design of current phase III trials
Duncan C Gilbert, Ruth E Langley, Dami Ayadi, et al.
Frontiers in Pharmacology
|
April 2, 2021
A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung)
Daniel Heudobler, Christian Schulz, Jürgen R Fischer, et al.
JCO Global Oncology
|
April 28, 2021
Trends in International Cancer Research Investment 2006-2018
Rachel Abudu, Gauthier Bouche, Karima Bourougaa, et al.
Cancers
|
April 13, 2023
Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)
Pierre Leblond, Emmanuelle Tresch-Bruneel, Alicia Probst, et al.
Plos One
|
December 5, 2019
Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial
Patrice Forget, Gauthier Bouche, Francois P Duhoux, et al.
Page
of 7